Relation of Mortality to Failure to Prescribe Beta Blockers Acutely in Patients With Sustained Ventricular Tachycardia and Ventricular Fibrillation Following Acute Myocardial Infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry)

American Journal of Cardiology

Volumn 102, Issue 11, 2008, Pages 1427-1432

  Piccini, Jonathan P ^a   Hranitzky, Patrick M ^a   Kilaru, Rakhi ^a   Rouleau, Jean Lucien ^b   White, Harvey D ^c   Aylward, Philip E ^d   Van de Werf, Frans ^e   Solomon, Scott D ^f   Califf, Robert M ^a   Velazquez, Eric J ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b MONTREAL HEART INSTITUTE   (Canada)

^c AUCKLAND CITY HOSPITAL   (New Zealand)

^d FLINDERS MEDICAL CENTRE   (Australia)

^e Leuven Coordinating Center   (Belgium)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; NITRATE; SPIRONOLACTONE; WARFARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CORRELATION ANALYSIS; DRUG USE; FEMALE; HEART FAILURE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; REGISTER;

ADRENERGIC BETA-ANTAGONISTS; AGED; CLINICAL TRIALS AS TOPIC; DEATH, SUDDEN, CARDIAC; DRUG PRESCRIPTIONS; FEMALE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PHYSICIAN'S PRACTICE PATTERNS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TACHYCARDIA, VENTRICULAR; TIME FACTORS; VENTRICULAR FIBRILLATION;

EID: 57149138316     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.07.033     Document Type: Article

References (30)

1. Solomon S.D., Zelenkofske S., McMurray J.J., Finn P.V., Velazquez E., Ertl G., Harsanyi A., Rouleau J.L., Maggioni A., Kober L., et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 352 (2005) 2581-2588
2. Jánosi A., Ghali J.K., Herlitz J., Czuriga I., Klibaner M., Wikstrand J., and Hjalmarson A. Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF. Am Heart J 146 (2003) 721-728
3. Gislason G.H., Abildstrom S.Z., Rasmussen J.N., Rasmussen S., Buch P., Gustafsson I., Friberg J., Gadsbøll N., Køber L., Stender S., and Madsen M. Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002. Scand Cardiovasc J 39 (2005) 42-49
4. Perschbacher J.M., Reeder G.S., Jacobsen S.J., Weston S.A., Killian J.M., Slobodora A., and Roger V.L. Evidence-based therapies for myocardial infarction: secular trends and determinants of practice in the community. Mayo Clin Proc 79 (2004) 983-991
5. Velazquez E.J., Francis G.S., Armstrong P.W., Aylward P.E., Diaz R., O'Connor C.M., White H.D., Henis M., Rittenhouse L.M., Kilaru R., et al. An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT Registry. Eur Heart J 25 (2004) 1911-1919
6. Al-Khatib S.M., Stebbins A.L., Califf R.M., Lee K.L., Granger C.B., White H.D., Armstrong P.W., Topol E.J., and Ohman E.M. Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial. Am Heart J 145 (2003) 515-521
7. Mehta R.H., Harjai K.J., Grines L., Stone G.W., Boura J., Cox D., O'Neill W., and Grines C.L. Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors, and outcomes. J Am Coll Cardiol 43 (2004) 1765-1772
8. Killip III T., and Kimball J.T. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 20 (1967) 457-464
9. Risk stratification and survival after myocardial infarction. N Engl J Med 309 (1983) 331-336
10. Maggioni A.P., Zuanetti G., Franzosi M.G., Rovelli F., Santoro E., Staszewsky L., Tavassi L., and Tognoni G. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation 87 (1993) 312-322
11. Henkel D.M., Witt B.J., Gersh B.J., Jacobsen S.J., Weston S.A., Meverden R.A., and Roger V.L. Ventricular arrhythmias after acute myocardial infarction: a 20-year community study. Am Heart J 151 (2006) 806-812
12. First International Study of Infarct Survival Collaborative Group. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 2 (1986) 57-66
13. Rydén L., Ariniego R., Arnman K., Herlitz J., Hjalmarson A., Holmberg S., Reyes C., Smedgård P., Svedberg K., Vedin A., et al. A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. N Engl J Med 308 (1983) 614-618
14. Lichstein E., Morganroth J., Harrist R., and Hubble E. Effect of propranolol on ventricular arrhythmia. The beta-blocker heart attack trial experience. Circulation 67 (1983) I5-I10
15. Braunwald E., Antman E.M., Beasley J.W., Califf R.M., Cheitlin M.D., Hochman J.S., Jones R.H., Kereiakes D., Kupersmith J., Levin T.N., et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 40 (2002) 1366-1374
16. Marciniak T.A., Ellerbeck E.F., Radford M.J., Kresowik T.F., Gold J.A., Krumholz H.M., Kiefe C.I., Allman R.M., Vogel R.A., and Jencks S.F. Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. JAMA 279 (1998) 1351-1357
17. McMurray J., Kober L., Robertson M., Dargie H., Colucci W., Lopez-Sendon J., Remme W., Sharpe D.N., and Ford I. Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. J Am Coll Cardiol 45 (2005) 525-530
18. Berger P.B., Ruocco N.A., Ryan T.J., Frederick M.M., and Podrid P.J. Incidence and significance of ventricular tachycardia and fibrillation in the absence of hypotension or heart failure in acute myocardial infarction treated with recombinant tissue-type plasminogen activator: results from the Thrombolysis In Myocardial Infarction (TIMI) phase II trial. J Am Coll Cardiol 22 (1993) 1773-1779
19. Roberts R., Rogers W.J., Mueller H.S., Lambrew C.T., Diver D.J., Smith H.C., Willerson J.T., Knatterud G.L., Forman S., and Passamani E. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis In Myocardial Infarction (TIMI) II-B Study. Circulation 83 (1991) 422-437
20. Metoprolol In Acute Myocardial Infarction (MIAMI). A randomised placebo-controlled international trial. Eur Heart J 6 (1985) 199-226
21. Hjalmarson A., Elmfeldt D., Herlitz J., Holmberg S., Málek I., Nyberg G., Rydén L., Swedberg K., Vedin A., Waagstein F., et al. Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet 2 (1981) 823-827
22. COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) Collaborative Group. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366 (2005) 1622-1632
23. Exner D.V., Reiffel J.A., Epstein A.E., Ledingham R., Reiter M.J., Yao Q., Duff H.J., Follmann D., Schron E., Greene H.L., et al. Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. J Am Coll Cardiol 34 (1999) 325-333
24. Brodine W.N., Tung R.T., Lee J.K., Hockstad E.S., Moss A.J., Zareba W., Hall W.J., Andrews M., McNitt S., and Daubert J.P. Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II). Am J Cardiol 96 (2005) 691-695
25. Jánosi A., Ghali J.K., Herlitz J., Czuriga I., Klibaner M., Wikstrand J., Hjalmarson A., and MERIT-HF Study Group. Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF. Am Heart J 146 (2003) 721-728
26. Nademanee K., Taylor R., Bailey W.E., Reiders D.E., and Kosar E.M. Treating electrical storm: sympathetic blockade versus advanced cardiac life support-guided therapy. Circulation 102 (2000) 742-747
27. Koenig W., Lowel H., Lewis M., and Hörmann A. Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985 to 1993. Eur Heart J 17 (1996) 1199-1206
28. Soumerai S.B., McLaughlin T.J., Spiegelman D., Hertzmark E., Thibault G., and Goldmann L. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA 277 (1997) 115-121
29. Miller C.D., Roe M.T., Mulgund J., Hoekstra J.W., Santos R., Pollack Jr. C.V., Ohman E.M., Gibler W.B., and Peterson E.D. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction. Am J Med 120 (2007) 685-692
30. Zipes D.P., Camm A.J., Borggrefe M., Buxton A.E., Chaitman B., Fromer M., Gregoratos G., Klein G., Moss A.J., Myerburg R.J., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114 (2006) e385-e484